CTOs on the Move

CardioMEMS

www.cardiomems.com

 
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Our technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Our miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients. Due to their small size, durability, and lack of wires and batteries, our sensors are designed to be permanently implanted into the cardiovascular system. Using radiofrequency, or RF, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cardiomems.com
  • 387 Technology Cir NW Ste 500
    Atlanta, GA USA 30313
  • Phone: 678.651.2300

Executives

Name Title Contact Details

Similar Companies

Cardo Medical Inc.

Cardo Medical Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Beverly Hills, CA. To find more information about Cardo Medical Inc., please visit www.cardomedical.com

Anthem

Anthem, Inc., is a provider of health insurance in the United States.

drchrono

drchrono is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SPARC

Cannabis dispensaries in San Francisco, Santa Rosa, and Sebastopol, SPARC offers same-day cannabis delivery in San Francisco and Sonoma County.

Histogenics

Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Histogenics` regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Histogenics` first investigational product candidate, NeoCart®, leverages its platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.